Incidence of Age-Related Macular Degeneration in the Central Region of Portugal: The Coimbra Eye Study – Report 5

Purpose: To describe the 6.5-year incidence and progression of age-related macular degeneration (AMD) in a coastal town of central Portugal. Methods: Population-based cohort study. Participants underwent standardized interviews and ophthalmological examination. Color fundus photographs were graded according to the International Classification and Grading System for AMD and ARM. The crude and age-standardized incidence of early and late AMD was calculated, and progression was analyzed. Results: The 6.5-year cumulative incidence of early AMD was 10.7%, and of late AMD it was 0.8%. The incidence of early AMD was 7.2, 13.1 and 17.7% for participants aged 55–64, 65–74 and 75–84 years (p < 0.001). The late AMD incidence was 0.3, 0.9 and 2.8% for the corresponding age groups (p = 0.003). The age-standardized incidence was 10.8% (95% CI, 10.74–10.80%) for early and 1.0% (95% CI, 1.00–1.02%) for late AMD. The incidence of both neovascular AMD and geographic atrophy was 0.4%. Progression occurred in 17.2% of patients. Conclusion: The early AMD incidence in a coastal town of central Portugal was found to be similar to that of major epidemiological studies of European-descent populations; however, the incidence of late AMD was lower, and further analysis on risk factors will be conducted.

[1]  L. Ribeiro,et al.  Adherence to a Mediterranean diet, lifestyle and age‐related macular degeneration: the Coimbra Eye Study – report 3 , 2018, Acta ophthalmologica.

[2]  J. Dartigues,et al.  Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study , 2018, JAMA ophthalmology.

[3]  Glenn J Jaffe,et al.  Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. , 2017, Ophthalmology.

[4]  P. Mitchell,et al.  Six-Year Incidence of Age-Related Macular Degeneration in Asian Malays: The Singapore Malay Eye Study. , 2017, Ophthalmology.

[5]  Nisha V. Shah,et al.  Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya , 2017, JAMA ophthalmology.

[6]  Inês Laíns,et al.  Automated Brightness and Contrast Adjustment of Color Fundus Photographs for the Grading of Age-Related Macular Degeneration , 2017, Translational vision science & technology.

[7]  J. Cunha-Vaz,et al.  Age‐related macular degeneration in Portugal: prevalence and risk factors in a coastal and an inland town. The Coimbra Eye Study – Report 2 , 2016, Acta ophthalmologica.

[8]  P. Mitchell,et al.  The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study. , 2015, Ophthalmology.

[9]  D. Cook,et al.  Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis. , 2015, American journal of ophthalmology.

[10]  J. Cunha-Vaz,et al.  Prevalence of Age-Related Macular Degeneration in Portugal: The Coimbra Eye Study - Report 1 , 2014, Ophthalmologica.

[11]  R. Klein,et al.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.

[12]  Gabriëlle H S Buitendijk,et al.  Harmonizing the Classification of Age-related Macular Degeneration in the Three-Continent AMD Consortium , 2014, Ophthalmic epidemiology.

[13]  M. Costa,et al.  Ocular Risk Factors for Exudative AMD: A Novel Semiautomated Grading System , 2013, ISRN ophthalmology.

[14]  Usha Chakravarthy,et al.  Clinical classification of age-related macular degeneration. , 2013, Ophthalmology.

[15]  J. Jonas,et al.  Five-year incidence of age-related macular degeneration: the Beijing Eye Study. , 2012, Ophthalmology.

[16]  Y. Kiyohara,et al.  Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. , 2009, Ophthalmology.

[17]  Ronald Klein,et al.  Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2007, Ophthalmology.

[18]  Ronald Klein,et al.  A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.

[19]  G. Jensen,et al.  14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. , 2005, Ophthalmology.

[20]  H. Taylor,et al.  Five-year incidence of age-related maculopathy: the Visual Impairment Project. , 2004, Ophthalmology.

[21]  T. Peto,et al.  5-year incidence of age-related maculopathy in the Reykjavik Eye Study. , 2003, Ophthalmology.

[22]  R. Klein,et al.  Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. , 2003, Ophthalmology.

[23]  A. Hofman,et al.  The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. , 2003, Archives of ophthalmology.

[24]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[25]  Paul Mitchell,et al.  Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.

[26]  M G Maguire,et al.  Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. , 1995, Archives of ophthalmology.

[27]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[28]  R. Klein,et al.  The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.

[29]  Paul Mitchell,et al.  Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. , 2007, Ophthalmology.

[30]  A Hofman,et al.  Incidence and progression rates of age-related maculopathy: the Rotterdam Study. , 2001, Investigative ophthalmology & visual science.

[31]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[32]  J M Gibson,et al.  Seven year follow-up of age-related maculopathy in an elderly British population , 1997, Eye.